Given that we found the differential expression of PLK1/2/3/4 in lung cancer, further identification of PLK1/2/3/4 expression pleads for an observation of their expression in lung cancer subtypes, including lung adenocarcinoma and lung squamous cell carcinoma. This evidence concerns the gene PLK1 and lung carcinoma.